Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 25 schizophrenia PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


schizophrenia PhD Projects, Programmes & Scholarships

We have 25 schizophrenia PhD Projects, Programmes & Scholarships

Biological rhythms and the dopamine system in cognitive dysfunction

  Research Group: Pharmacology and Experimental Therapeutics
Psychiatric disorders such as schizophrenia are associated with metabolic syndrome, obesity and diabetes. Schizophrenia affects 1.1% of the population and although not the most common psychiatric condition it is arguably the most severe and debilitating. Read more

Molecular characterisation of a novel transporter for the atypical antipsychotic clozapine

Schizophrenia is a severe psychiatric illness affecting about 24 million people worldwide. Schizophrenia can have a devastating effect on a patient’s life and is associated with increased mortality, with life expectancy reduced on average by 15 years compared to that of the general population. Read more

Gut Microbiome, Immune Response and Risk of Neuropsychiatric Conditions

Rationale. Low-grade systemic inflammation is associated with risk of neuropsychiatric conditions such as depression, schizophrenia, autism, with emerging genetic evidence suggesting a potentially causal role of inflammatory cytokines such as interleukin 6 (IL-6) in these conditions (1, 2). Read more

Neural underpinnings of naturalistic speech rhythms underlying disorganised thought processing and the impact of vocal emotions on emotional states in clinical high-risk using OPM-MEG

Person Specification. Applicants should have a strong background in neuroscience, mental health research, psychology, medicine, physics, computer science, experimental linguistics or a related discipline relevant to cognitive neuroscience/neuroimaging, and ideally a background in cognitive neuroimaging. Read more

Developing biodegradable long acting drug delivery systems for the treatment of chronic conditions

Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more

Antipsychotic withdrawal – mapping support mechanisms and outcome predictors through lived experiences

Prescribing antipsychotics has increased steadily in England over the last decade. For serious mental health conditions like schizophrenia, they are prescribed with the view of keeping the patient on them indefinitely. Read more

Integrative model of inflammation, cognition and brain changes in individuals with psychosis

Additional supervisor. Dr Zia Katshu - mohammad.katshu@nottingham.ac.uk. Person Specification. Applicants should have a strong background in clinical neuroscience, cognitive neuroscience or neuroimaging, and ideally a background in mental health, advanced multivariate statistical analyses or data science. Read more

Enzyme-responsive peptide hydrogels as in situ forming long-acting drug delivery implants

One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more

Filtering Results